Renovacor Announces the Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer

Renovacor Announces the Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer

Dr. Killeen joins Renovacor from BioMarin where he led the discovery and development of AAV-based gene therapies for inherited cardiac diseases 

See more here